Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 96,699
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12600750 | Methods for inactivating and storing respiratory syncytial virus | 🖼🧊📄§ | 2026-04-14 | 2039-07-08 | 0 | 31 |
| 12600733 | KRAS inhibitors | 🖼🧊📄§ | 2026-04-14 | 2045-09-30 | 0 | 31 |
| 12600959 | PH20 polypeptide variants, formulations and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2045-03-05 | 0 | 31 |
| 12600778 | Rage antibodies, fragments and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2040-11-02 | 0 | 31 |
| 12600782 | Anti-PD-L1 and PD-L2 antibody and derivatives and use thereof | 🖼🧊📄§ | 2026-04-14 | 2041-03-30 | 0 | 31 |
| 12600796 | Constructs for chimeric antigen receptors | 🖼🧊📄§ | 2026-04-14 | 2041-09-16 | 0 | 31 |
| 12600968 | Methods and compositions for reprogramming cells | 🖼🧊📄§ | 2026-04-14 | 2042-07-20 | 0 | 31 |
| 12600790 | Variant antibody that binds CD38 | 🖼🧊📄§ | 2026-04-14 | 2040-12-18 | 0 | 31 |
| 12600967 | SiRNA compound that inhibits complement factor B (CFB) | 🖼🧊📄§ | 2026-04-14 | 2042-07-18 | 0 | 31 |
| 12600760 | Chimeric antigen receptors targeting CD79B and CD19 | 🖼🧊📄§ | 2026-04-14 | 2039-12-13 | 0 | 31 |
| 12594320 | Method for treating checkpoint inhibitors induced adverse events | 🖼🧊📄§ | 2026-04-07 | 2040-02-03 | 0 | 31 |
| 12594234 | Use of an epilobium fleischeri extract | 🖼🧊📄§ | 2026-04-07 | 2041-09-17 | 0 | 31 |
| 12595307 | Anti-CTLA4 monoclonal antibodies and chimeric antigen receptors | 🖼🧊📄§ | 2026-04-07 | 2041-06-09 | 0 | 31 |
| 12594254 | Intranasal administration of n-acetylcysteine and uses thereof | 🖼🧊📄§ | 2026-04-07 | 2043-02-07 | 0 | 31 |
| 12594245 | Dry powder formulations for messenger RNA | 🖼🧊📄§ | 2026-04-07 | 2042-05-16 | 0 | 31 |
| 12594224 | Oral care compositions and methods of use | 🖼🧊📄§ | 2026-04-07 | 2042-09-23 | 0 | 31 |
| 12594275 | Immunophilin binding agents and uses thereof | 🖼🧊📄§ | 2026-04-07 | 2040-02-06 | 0 | 31 |
| 12595469 | Treatment of retinitis pigmentosa using improved engineered meganucleases | 🖼🧊📄§ | 2026-04-07 | 2041-05-11 | 0 | 31 |
| 12596122 | LILRB2 antibodies and uses thereof | 🖼🧊📄§ | 2026-04-07 | 2041-01-28 | 0 | 31 |
| 12595464 | Method of producing retinal pigment epithelial cell | 🖼🧊📄§ | 2026-04-07 | 2045-02-25 | 0 | 31 |
| 12595485 | Modulation of prekallikrein (PKK) expression | 🖼🧊📄§ | 2026-04-07 | 2043-10-18 | 0 | 31 |
| 12595175 | Calcium phosphate-based core-shell structured material, method for preparing the same, and oral care composition using the same | 🖼🧊📄§ | 2026-04-07 | 2042-06-21 | 0 | 31 |
| 12595226 | Carbonate containing lipid compounds and compositions for intracellular delivery of therapeutic agents | 🖼🧊📄§ | 2026-04-07 | 2040-09-18 | 0 | 31 |
| 12595237 | Lamotrigine hydrate crystal form, preparation method therefor, and composition containing same | 🖼🧊📄§ | 2026-04-07 | 2042-04-18 | 0 | 31 |
| 12595244 | Small molecule inhibitors of mammalian SLC6A19 function | 🖼🧊📄§ | 2026-04-07 | 2045-05-30 | 0 | 31 |
| 12595251 | Amidines and amidine analogs for the treatment of bacterial infections and potentiation antibiotics | 🖼🧊📄§ | 2026-04-07 | 2039-06-13 | 0 | 31 |
| 12595265 | Inhibitors of activin receptor-like kinase | 🖼🧊📄§ | 2026-04-07 | 2043-04-20 | 0 | 31 |
| 12595264 | Heterocyclic GLP-1 agonists | 🖼🧊📄§ | 2026-04-07 | 2041-09-08 | 0 | 31 |
| 12595269 | Morpholine-like monoamine releasers | 🖼🧊📄§ | 2026-04-07 | 2043-02-16 | 0 | 31 |
| 12595275 | Fluorine-containing compound and anti-cancer medical use thereof | 🖼🧊📄§ | 2026-04-07 | 2040-05-12 | 0 | 31 |
| 12595288 | Vasopressin-2 receptor antagonist peptides and uses thereof | 🖼🧊📄§ | 2026-04-07 | 2041-06-23 | 0 | 31 |
| 12595289 | Therapeutic agent for breast cancer comprising BIG3-PHB2 interaction-inhibiting peptide derived from PHB2 | 🖼🧊📄§ | 2026-04-07 | 2039-11-28 | 0 | 31 |
| 12595291 | Engineered immune cells with micro-clusters | 🖼🧊📄§ | 2026-04-07 | 2041-09-21 | 0 | 31 |
| 12595299 | FC variants | 🖼🧊📄§ | 2026-04-07 | 2041-10-05 | 0 | 31 |
| 12595297 | Methods and compositions for inhibition of EGF/EGFR pathway in combination with tyrosine kinase inhibitors | 🖼🧊📄§ | 2026-04-07 | 2036-03-17 | 0 | 31 |
| 12595306 | TREM2 stabilizing antibodies | 🖼🧊📄§ | 2026-04-07 | 2044-12-23 | 0 | 31 |
| 12595305 | TREM2 stabilizing antibodies | 🖼🧊📄§ | 2026-04-07 | 2042-09-23 | 0 | 31 |
| 12595301 | Anti-il-2 antibodies and compositions and uses thereof | 🖼🧊📄§ | 2026-04-07 | 2042-09-16 | 0 | 31 |
| 12595311 | Chimeric antigen receptors and related methods and compositions for the treatment of cancer | 🖼🧊📄§ | 2026-04-07 | 2041-03-02 | 0 | 31 |
| 12595309 | Compositions and methods for treatment of thyroid eye disease | 🖼🧊📄§ | 2026-04-07 | 2044-11-08 | 0 | 31 |
| 12595312 | CD133-binding agents and uses thereof | 🖼🧊📄§ | 2026-04-07 | 2041-10-26 | 0 | 31 |
| 12595336 | Method for producing maleimide polyethylene glycol derivative | 🖼🧊📄§ | 2026-04-07 | 2041-12-08 | 0 | 31 |
| 12595358 | Enhancement of rubber by heat-assisted migration from ancillary rubber | 🖼🧊📄§ | 2026-04-07 | 2043-06-05 | 0 | 31 |
| 12595372 | High-hydrophobic, low-bleeding color lake powder, method for preparing same and use thereof | 🖼🧊📄§ | 2026-04-07 | 2041-09-30 | 0 | 31 |
| 12594559 | Powderized cannabis and uses thereof | 🖼🧊📄§ | 2026-04-07 | 2042-05-09 | 0 | 31 |
| 12594577 | Rotary reactor for deposition of films onto particles | 🖼🧊📄§ | 2026-04-07 | 2042-10-21 | 0 | 31 |
| 12594421 | Compositions and methods for increasing cancer cell sensitivity to alternating electric fields | 🖼🧊📄§ | 2026-04-07 | 2041-08-03 | 0 | 31 |
| 12594227 | Tetrapeptide and compositions comprising tetrapeptides | 🖼🧊📄§ | 2026-04-07 | 2041-11-16 | 0 | 31 |
| 12594228 | Composition for hair protection or hair strengthening | 🖼🧊📄§ | 2026-04-07 | 2045-03-12 | 0 | 31 |
| 12594229 | Personal care compositions and methods for the same | 🖼🧊📄§ | 2026-04-07 | 2040-12-04 | 0 | 31 |